跳至主要内容
临床试验/NCT00508378
NCT00508378已完成不适用

Chemotherapy-Related Toxicities In Ovarian Cancer Patients: Preference Assessments of Patients, Family Members, Ancillary Staff and Gynecologic Oncologists, and Patients' Quality of Life

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 288 人开始时间: 2001年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
288
试验地点
1
主要终点
Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.

研究概览

简要总结

Primary Objectives:

  1. To assess the preferences of women with ovarian cancer, their clinical caregivers, familial caregivers, and a control group for toxicities associated with chemotherapy.
  • To compare preferences of women with ovarian cancer to preferences of their clinical caregivers.
  • To compare preferences of women with ovarian cancer to preferences of their familial caregivers.
  • To compare preferences of women with ovarian cancer to preferences of a women in the control group.
  1. To prospectively collect quality of life data from women with ovarian cancer.
  2. To prospectively collect symptom assessment data from women with ovarian cancer.

详细描述

Patients in this study will be recruited from the Gynecologic Oncology Clinic waiting area. All participants (patients, family and clinical caregivers, control group women with no cancer) in this study will take part in an interview to see how they feel about the different side-effects of chemotherapy. The interview will involve reading short descriptions of the side-effects and then answering some questions that ask for an opinion. The actual interview will take about 30-45 minutes to complete. The interviews will either take place in private conference rooms in the clinic or in private rooms at the Ambulatory Treatment Center (ATC).

Patients will also be given quality of life and symptom assessment questionnaires. The questionnaires are simple to read and quick to answer. The questionnaire takes about 15 minutes to complete.

The participant's involvement in this study is limited to the questionnaire/interview. Once that is done, the participant is finished with the study.

This is an investigational study. A total of 288 people will take part in this study. All will be enrolled at M. D. Anderson.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology Clinic who are currently undergoing chemotherapy
  • Women with a history of epithelial ovarian cancer presenting to the UTMDACC Gynecologic Oncology Clinic who are seen in follow-up
  • Women who are at least 18 years of age
  • Women who speak English
  • Clinical caregivers of patients with ovarian cancer (UTMDACC gynecologic oncologists, UTMDACC gynecologic medical oncologists, UTMDACC registered nurses and licensed vocational nurses in the UTMDACC Gynecology Clinic, and UTMDACC gynecologic oncology fellows and residents)
  • Familial caregivers of patients with ovarian cancer (primary caregiver)

排除标准

  • Participants who are non-English speakers
  • Participants who are less than 18 years of age

结局指标

主要结局

Qualitative information on how ovarian cancer patients, their family members, and doctors and nurses feel about the side-effects of chemotherapy.

时间窗: 8 Years

次要结局

  • Patient Response to Quality of Life Using Interview + Questionnaire(30 minute interviews + 15 minutes for questionnaire)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Search for Predictors of Therapeutic Response in Ovarian CarcinomaCarcinoma of the OvaryFallopian Tube CancerPeritoneal Serous-type Advanced Stage
NCT01391351Centre Francois Baclesse107
Unknown
不适用
Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerStage I Ovarian Cancer AJCC v6 and v7Stage IA Fallopian Tube Cancer AJCC v6 and v7Stage IB Fallopian Tube Cancer AJCC v6 and v7Stage IC Fallopian Tube Cancer AJCC v6 and v7Stage II Ovarian Cancer AJCC v6 and v7Stage IIA Fallopian Tube Cancer AJCC v6 and v7Stage IIB Fallopian Tube Cancer AJCC v6 and v7Stage IIC Fallopian Tube Cancer AJCC v6 and v7Stage III Ovarian Cancer AJCC v6 and v7Stage III Primary Peritoneal Cancer AJCC v7Stage IIIA Fallopian Tube Cancer AJCC v7Stage IIIB Fallopian Tube Cancer AJCC v7Stage IIIC Fallopian Tube Cancer AJCC v7Stage IV Fallopian Tube Cancer AJCC v6 and v7Stage IV Ovarian Cancer AJCC v6 and v7Stage IV Primary Peritoneal Cancer AJCC v7
NCT01366183Gynecologic Oncology Group290
撤回
不适用
Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian CancerOvarian Cancer
NCT01606358Rennes University Hospital
Unknown
不适用
Retrospective Study of Ovarian Cancer Patients With Brain MetastasisBrain MetastasesOvarian Cancer
NCT01258881National Taiwan University Hospital70
进行中(未招募)
不适用
Ovarian Reserve After Cancer: Longitudinal EffectsEffects of ChemotherapyPremature Ovarian Failure
NCT02467231University of Pennsylvania196